Home > Clinical Trials
Check All Search

Saved trials

NOT_YET_RECRUITING
NCT07630103
Efficacy and Safety of Trastuzumab Rezetecan or Trastuzumab Deruxtecan in Advanced Breast Cancer
100 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
Advanced Breast Cancer
NOT_YET_RECRUITING
NCT07629635
Migraine Headaches Elimination With Patent Foramen Ovale-Directed Therapy
32 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE3)
Migraine Disease


Patent Foramen Ovale
RECRUITING
NCT07195149
Comparing High and lOw-dose asPirin With Dual anTIplatelet Therapy for Three Months Using prasUgrel and aSpirin Following Coronary Artery Bypass Grafting. (OPTIMUS-CABG Trial)
1,703 Enrollment(s)
18 Study location(s)
INTERVENTIONAL (PHASE3)
Chronic Coronary Syndrome


Stable Coronary Artery Disease CAD
RECRUITING
NCT04585958
Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Platinum Resistant Ovarian Cancer
55 Enrollment(s)
7 Study location(s)
INTERVENTIONAL (PHASE1)
Metastatic Malignant Solid Neoplasm


Platinum-Resistant Ovarian High Grade Serous Adenocarcinoma


Unresectable Malignant Solid Neoplasm
ACTIVE_NOT_RECRUITING
NCT07610577
Use and Costs of P2Y12 Inhibitors After Acute Myocardial Infarction
377,753 Enrollment(s)
1 Study location(s)
OBSERVATIONAL (None)
Acute Myocardial Infarction (AMI)
RECRUITING
NCT07086768
Dose-Escalation and Dose-Expansion Study of BSI-082 Monotherapy and Combined Therapy in Patients With Advanced or Metastatic Solid Tumors
57 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE1)
Solid Tumor


Advanced Solid Tumor


Metastatic Solid Tumor
NOT_YET_RECRUITING
NCT07619365
Trastuzumab Deruxtecan and Lovastatin in HER2-low and Ultralow Advanced or Metastatic Breast Cancer
60 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
Breast Cancer


Advanced Breast Cancer


Metastatic Breast Cancer
RECRUITING
NCT06486883
Safety and Efficacy of T-DXd vs. CDK4/6i-based ET as First-line Therapy of HR-positive and HER2-low/Ultralow Advanced Breast Cancer Patients Classified as Non-luminal Subtype
200 Enrollment(s)
72 Study location(s)
INTERVENTIONAL (PHASE2)
Advanced Breast Cancer


Advanced Breast Carcinoma


Hormone Receptor Positive Breast Carcinoma